CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-14 | Turner Kathy V Senior Vice President | Option exercise · Restricted Stock Unit | −162 | 972 | ||
| 2023-02-14 | Turner Kathy V Senior Vice President | Option exercise · Restricted Stock Unit | −86 | 886 | ||
| 2023-02-14 | Turner Kathy V Senior Vice President | Option exercise · Restricted Stock Unit | −93 | 793 | ||
| 2023-02-14 | Turner Kathy V Senior Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −2,000 | 4,736 | ||
| 2023-02-14 | Smith Martin Alexander Executive Vice President | Option exercise | +149 | 227 | ||
| 2023-02-14 | Smith Martin Alexander Executive Vice President | Shares withheld for taxes | +47 | $503.65 | $24K | 180 |
| 2023-02-14 | Smith Martin Alexander Executive Vice President | Option exercise · Restricted Stock Unit | −149 | 1,846 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +126 | 15,555.28 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +127 | 15,682.28 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +216 | 15,898.28 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +161 | 16,605.28 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +204 | 16,263.28 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Shares withheld for taxes | +252 | $503.65 | $127K | 16,011.28 |
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Restricted Stock Unit | −126 | 2,863 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Restricted Stock Unit | −127 | 2,736 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Restricted Stock Unit | −216 | 2,520 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Restricted Stock Unit | −161 | 2,359 | ||
| 2023-02-14 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Restricted Stock Unit | −204 | 2,155 | ||
| 2023-02-14 | MCKEON BRIAN P Executive VP & CFO | Option exercise | +504 | 28,814.64 | ||
| 2023-02-14 | MCKEON BRIAN P Executive VP & CFO | Option exercise | +435 | 29,249.64 |
Page 47 of 52 · 1,036 trades